Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Ipragliflozin> ?p ?o }
Showing triples 1 to 47 of
47
with 100 triples per page.
- Ipragliflozin abstract "Ipragliflozin (Suglat) is a pharmaceutical drug for treatment of type 2 diabetes. It was approved for use in Japan in 2014.Ipragliflozin is an SGLT2 inhibitor.".
- Ipragliflozin thumbnail Ipragliflozin.svg?width=300.
- Ipragliflozin wikiPageID "47596524".
- Ipragliflozin wikiPageLength "2774".
- Ipragliflozin wikiPageOutDegree "5".
- Ipragliflozin wikiPageRevisionID "707011211".
- Ipragliflozin wikiPageWikiLink Category:Benzothiophenes.
- Ipragliflozin wikiPageWikiLink Category:Glucosides.
- Ipragliflozin wikiPageWikiLink Category:SGLT2_inhibitors.
- Ipragliflozin wikiPageWikiLink Diabetes_mellitus_type_2.
- Ipragliflozin wikiPageWikiLink Gliflozin.
- Ipragliflozin wikiPageWikiLinkText "Ipragliflozin".
- Ipragliflozin wikiPageWikiLinkText "ipragliflozin".
- Ipragliflozin c "21".
- Ipragliflozin chembl "2018096".
- Ipragliflozin chemspiderid "8629286".
- Ipragliflozin f "1".
- Ipragliflozin h "21".
- Ipragliflozin iupacName "-15".
- Ipragliflozin kegg "D10196".
- Ipragliflozin molecularWeight "404.45".
- Ipragliflozin o "5".
- Ipragliflozin pubchem "10453870".
- Ipragliflozin s "1".
- Ipragliflozin smiles "S1CCC=2C=C[C@H]2[C@H][C@@H][C@H][C@H]CO".
- Ipragliflozin stdinchi "1".
- Ipragliflozin stdinchikey "AHFWIQIYAXSLBA-RQXATKFSSA-N".
- Ipragliflozin tradename "Suglat".
- Ipragliflozin wikiPageUsesTemplate Template:Infobox_drug.
- Ipragliflozin wikiPageUsesTemplate Template:Pharma-stub.
- Ipragliflozin wikiPageUsesTemplate Template:Reflist.
- Ipragliflozin subject Category:Benzothiophenes.
- Ipragliflozin subject Category:Glucosides.
- Ipragliflozin subject Category:SGLT2_inhibitors.
- Ipragliflozin hypernym Drug.
- Ipragliflozin type ChemicalSubstance.
- Ipragliflozin type Drug.
- Ipragliflozin type ChemicalObject.
- Ipragliflozin type Thing.
- Ipragliflozin type Q8386.
- Ipragliflozin comment "Ipragliflozin (Suglat) is a pharmaceutical drug for treatment of type 2 diabetes. It was approved for use in Japan in 2014.Ipragliflozin is an SGLT2 inhibitor.".
- Ipragliflozin label "Ipragliflozin".
- Ipragliflozin sameAs Q21098969.
- Ipragliflozin sameAs Q21098969.
- Ipragliflozin wasDerivedFrom Ipragliflozin?oldid=707011211.
- Ipragliflozin depiction Ipragliflozin.svg.
- Ipragliflozin isPrimaryTopicOf Ipragliflozin.